Clinical Infectious Diseases· 2026Q1
Reflections for the Future of AMR Surveillance and AMR Action
- 1citations
- Q1SCImago
- 2026year
Short summary
Future antimicrobial resistance (AMR) surveillance and action in low- and middle-income countries requires a sharpened focus on data scope, frequency, and depth, alongside sustainable, country-led financing models.
AI-generated from the title and abstract; the full text is not read.
Key points
- Future AMR surveillance must be planned within resource constraints, focusing data scope, frequency, and depth to drive action.
- Sustainability of AMR surveillance and action relies on country-led approaches supported by diverse financing.
- Significant progress has been made, but continued investment is needed from public, private, and multilateral sources.
- Well-designed, targeted, and cost-effective investments are crucial for maintaining capacity and strengthening systems.
AI-generated from the title and abstract; the full text is not read.
Abstract
BACKGROUND: This paper builds on the other papers in this series to present high-level lessons learnt and considerations for the future of antimicrobial resistance (AMR) surveillance and its contribution to action on AMR in low- and middle-income countries. METHODS: Participatory synthesis involved engagement with individuals who had worked within and alongside the Fleming Fund from a range of organizations and geographies, to scope and solidify lessons learnt and future considerations relevant to a wide range of donors, partners, and policy makers or implementors. Contributors were invited to join a Writing Group, which included individuals from academia, clinical sciences, applied public, animal, environment, and food sciences health, as well as senior scientists and administrators from 14 organizations. The synthesis was informed by contributions to 4 virtual workshops and 3 drafts of the manuscript. Authors read and commented on the drafts, several wrote and referenced sections, and all gave substantive feedback with their reactions to the draft conclusions as consensus was built. RESULTS: Over nearly 10 years, the Fleming Fund achieved significant improvements in AMR surveillance. Analysis of the barriers and enablers across settings and systems highlights key lessons for how surveillance is positioned, funded, used, and innovated upon. The success of future AMR surveillance and its sustainability relies on planning within resource constraints for a sharpened system that focuses the scope, frequency, and depth of data to inform action, technical, and architectural developments directions to streamline investment and financing that supports country-led sustainable approaches. CONCLUSIONS: Investment in AMR surveillance and broader AMR actions has yielded substantial progress. Expanded domestic public financing, large-scale private sector engagement, or enhanced multilateral support will be needed to ensure recent gains are sustained. Progress will require well-designed, targeted, and cost-effective investments to maintain current capacity while enabling further system strengthening.
The authors' abstract, as published at the source. Clinical Infectious Diseases, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Applied Microbiology and BiotechnologyImmunology and Microbiology